Viewray (VRAYQ) Stock Price & Analysis
VRAYQ Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $4.96
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 2.17M
- Market Cap
- $183
- Enterprise Value
- $634.64M
- Total Cash (Recent Filing)
- $81.29M
- Total Debt (Recent Filing)
- $85.13M
- Price to Earnings (P/E)
- 0.0
- Beta
- 13.23
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
VRAYQ FAQ
What was Viewray’s price range in the past 12 months?
What is Viewray’s market cap?
When is Viewray’s upcoming earnings report date?
How were Viewray’s earnings last quarter?
Is Viewray overvalued?
Does Viewray pay dividends?
What is Viewray’s EPS estimate?
How many shares outstanding does Viewray have?
What happened to Viewray’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Viewray?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Viewray
ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Paul Ziegler
- Employees
- 295
- Website
- www.viewraysystems.com
- Address
- 2 Thermo Fisher Way, Oakwood Village, OH, 44146, US
